Last Price$462.3(1.0%)
Market Cap$223.9B
LIN Intrinsic Value
Intrinsic Value of LIN Overview
Key Highlights:
As of Mar 03, 2025 LIN Relative Value is $281.5, which is overvalued by 39.1%, compared to current share price of $462.3.
As of Mar 03, 2025 LIN DCF Value is N/A, which is undervalued by N/A, compared to current share price of $462.3.
LIN Historical Intrinsic Value
Crunching data... Almost there!
Crunching data... Almost there!
LIN Valuation Metrics
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
7.3x (as of Mar 03, 2025)
EV/Gross Profit
17.3x (as of Mar 03, 2025)
EV/EBIT
27.9x (as of Mar 03, 2025)
EV/EBITDA
19.3x (as of Mar 03, 2025)
EV/FCF
48.9x (as of Mar 03, 2025)
EV/OCF
25.5x (as of Mar 03, 2025)
P/Revenue
6.8x (as of Mar 03, 2025)
P/Gross Profit
16.1x (as of Mar 03, 2025)
P/EBIT
25.9x (as of Mar 03, 2025)
P/EBITDA
17.9x (as of Mar 03, 2025)
P/FCF
45.4x (as of Mar 03, 2025)
P/OCF
23.8x (as of Mar 03, 2025)
P/E
34.1x (as of Mar 03, 2025)
P/BV
5.7x (as of Mar 03, 2025)
PEG 1Y
1.6x (as of Mar 03, 2025)
LIN DCF Model
Free Cash Flow to Firm Model
NOPAT Model
Free Cash Flow to Equity Model
Net Income Model
Millions
Billions
| Dec'19 Actual | Dec'20 Actual | Dec'21 Actual | Dec'22 Actual | Dec'23 Actual | Dec'24 Estimate | Dec'25 Estimate | Dec'26 Estimate | Dec'27 Estimate | Dec'28 Estimate | Dec'29 Estimate | Dec'30 Estimate | Dec'31 Estimate | Dec'32 Estimate | Dec'33 Estimate | Dec'34 Terminal | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 28,228.0 89.4% | 27,243.0 (3.5%) | 30,793.0 13.0% | 33,364.0 8.3% | 32,854.0 (1.5%) | 33,323.1 1.4% | 34,848.3 4.6% | 36,901.4 5.9% | 38,592.6 4.6% | 40,698.5 5.5% | 42,684.8 4.9% | 44,522.1 4.3% | 46,182.1 3.7% | 47,637.8 3.2% | 48,865.0 2.6% | 49,842.3 2.0% |
% margin | 2,933.0 10.4% | 3,322.0 12.2% | 4,984.0 16.2% | 5,369.0 16.1% | 8,024.0 24.4% | 6,024.2 18.1% | 6,300.0 18.1% | 6,671.1 18.1% | 6,976.9 18.1% | 7,357.6 18.1% | 7,716.6 18.1% | 8,048.8 18.1% | 8,348.9 18.1% | 8,612.1 18.1% | 8,833.9 18.1% | 9,010.6 18.1% |
NOPAT % effective tax rate | 2,162.4 7.7% | 2,490.5 9.1% | 3,750.5 12.2% | 3,980.0 11.9% | 6,201.8 18.9% | 4,656.2 14.0% | 4,869.3 14.0% | 5,156.2 14.0% | 5,392.5 14.0% | 5,686.7 14.0% | 5,964.3 14.0% | 6,221.0 14.0% | 6,452.9 14.0% | 6,656.3 14.0% | 6,827.8 14.0% | 6,964.4 14.0% |
% of revenue | 4,675.0 16.6% | 4,626.0 17.0% | 4,635.0 15.1% | 4,204.0 12.6% | 3,816.0 11.6% | 4,361.7 13.1% | 4,561.4 13.1% | 4,830.1 13.1% | 5,051.5 13.1% | 5,327.1 13.1% | 5,587.1 13.1% | 5,827.6 13.1% | 6,044.9 13.1% | 6,235.4 13.1% | 6,396.0 13.1% | 6,524.0 13.1% |
% of revenue | (3,682.0) (13.0%) | (3,400.0) (12.5%) | (3,086.0) (10.0%) | (3,173.0) (9.5%) | (3,787.0) (11.5%) | (3,449.9) (10.4%) | (3,607.8) (10.4%) | (3,820.4) (10.4%) | (3,995.5) (10.4%) | (4,213.5) (10.4%) | (4,419.1) (10.4%) | (4,609.3) (10.4%) | (4,781.2) (10.4%) | (4,931.9) (10.4%) | (5,059.0) (10.4%) | (5,160.1) (10.4%) |
% of revenue | (88.0) (0.3%) | 236.0 0.9% | 1,072.0 3.5% | (153.0) (0.5%) | (483.0) (1.5%) | 172.5 0.5% | 180.4 0.5% | 191.0 0.5% | 199.7 0.5% | 210.6 0.5% | 220.9 0.5% | 230.4 0.5% | 239.0 0.5% | 246.5 0.5% | 252.9 0.5% | 257.9 0.5% |
Free Cash Flow to Firm (FCFF) % of revenue | 3,067.4 10.9% | 3,952.5 14.5% | 6,371.5 20.7% | 4,858.0 14.6% | 5,747.8 17.5% | 5,740.4 17.2% | 6,003.2 17.2% | 6,356.9 17.2% | 6,648.2 17.2% | 7,011.0 17.2% | 7,353.1 17.2% | 7,669.7 17.2% | 7,955.6 17.2% | 8,206.4 17.2% | 8,417.8 17.2% | 8,586.1 17.2% |
% of FCFF used in calculation | ||||||||||||||||
Discount period | ||||||||||||||||
Discount factor | ||||||||||||||||
Discounted FCFF (DFCFF) |
LIN DCF Value
Crunching data... Almost there!
LIN Earnings Power Value and Enterprise Value
Annual
LTM
Enterprise Value Breakdown
EPV and MIVoG as % of EV
LIN Reverse DCF
Implied FCF growth
Implied Revenue growth
Reverse DCF Assumptions and Outputs
as of Dec 31, 2024
4,926.0M
Long-Term growth rate
2.0%
FX rate
1.0
Last share price
418.7
Implied FCF growth 1-10Y
0.0%
Implied Free Cash Flow growth vs Historical average vs Industry growth
Competing with LIN Intrinsic Value
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Enterprise Value | Intrinsic Value | DCF Value | Relative value | Ben Graham Revised fair value | Peter Lynch fair value | Earnings Power Value (EPV),
% of EV | Market-Implied Value of Growth (MIVoG),
% of EV | Reverse DCF (implied FCF growth) | Reverse DCF (implied Revenue growth) |
$223.9B | $240.7B | $277.7 39.9% overvalued | N/A | $277.7 39.9% overvalued | $338.2 26.8% overvalued | $221.6 52.1% overvalued | N/A | N/A | 0.0% | 0.0% | |
$91.2B | $102.9B | $146.6 58.9% overvalued | $79.4 78.0% overvalued | $213.8 40.1% overvalued | $245.9 31.1% overvalued | $173.0 51.5% overvalued | 34.5% | 65.5% | 20.3% | 16.1% | |
$76.9B | $83.8B | $124.7 53.8% overvalued | $103.0 62.0% overvalued | $146.3 45.8% overvalued | $286.2 6.1% undervalued | $186.5 30.9% overvalued | 36.5% | 63.5% | 17.0% | 13.4% | |
$70.4B | $83.5B | $149.5 51.9% overvalued | $75.2 76.0% overvalued | $223.8 28.0% overvalued | Negative 188.6% overvalued | Negative 141.2% overvalued | 68.9% | 31.1% | (100.0%) | (100.0%) | |
$33.6B | $38.9B | $49.1 37.7% overvalued | $10.3 87.0% overvalued | $87.9 11.6% undervalued | $145.7 84.8% undervalued | $79.2 0.5% undervalued | 32.0% | 68.0% | 4.4% | 9.7% | |
$26.3B | $31.4B | $112.5 0.7% undervalued | $59.8 46.0% overvalued | $165.2 47.9% undervalued | $224.8 101.2% undervalued | $140.7 26.0% undervalued | 49.8% | 50.2% | 13.7% | 8.6% | |
$24.5B | $34.0B | $190.6 159.6% undervalued | $166.9 127.0% undervalued | $214.2 191.8% undervalued | $23.1 68.5% overvalued | $56.7 22.8% overvalued | 67.1% | 32.9% | (6.4%) | (6.5%) | |
$21.0B | $29.5B | $40.0 50.6% overvalued | $2.3 97.0% overvalued | $77.7 4.0% overvalued | Negative 237.0% overvalued | N/A | 39.2% | 60.8% | 15.0% | 6.1% | |
$15.9B | $15.9B | $91.0 26.1% overvalued | $40.6 67.0% overvalued | $141.3 14.8% undervalued | $44.2 64.1% overvalued | $86.4 29.8% overvalued | 46.9% | 53.1% | 7.1% | 4.6% | |
$14.2B | $11.3B | $217.6 100.1% undervalued | $155.7 43.0% undervalued | $279.4 157.0% undervalued | $297.6 173.7% undervalued | $200.5 84.5% undervalued | 47.9% | 52.1% | 23.0% | 10.0% | |
$11.1B | $11.7B | $19.2 21.0% undervalued | $11.7 27.0% overvalued | $26.7 68.5% undervalued | $11.5 27.3% overvalued | $10.9 31.5% overvalued | 26.7% | 73.3% | 4.8% | 6.7% |
Intrinsic Valuation Tools
Wondering how to calculate intrinsic value of a stock? Use our intrinsic value tools to simplify complex valuation concepts and save time.